You are here Home Resources and guidance Sponsors Celltrion Healthcare Australia Pty Ltd Regulatory activities for this sponsor. Listen Print Share LinkedIn (Twitter) Facebook Email Loading... Type ARTG (38) Cancellation by sponsor (14) Prescription medicine registration (8) Australian public assessment report (AusPar) (7) Prescription medicine decision summary (2) Designation or determination (1) Prescription medicine evaluation (1) Date 2026 (1) 2025 (22) 2024 (10) 2023 (18) 2022 (6) 2021 (4) 2020 (5) 2019 (1) 2018 (3) 2015 (1) Search Sponsor content71 result(s) found, displaying 71 to 71 REMSIMA infliximab (rmc) 100mg Powder for Injection vial (217065) 27 November 2015 ARTG Australian Register of Therapeutic Goods (ARTG) information for REMSIMA infliximab (rmc) 100mg Powder for Injection vial. Pages First page « First Previous page ‹ Previous Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8
REMSIMA infliximab (rmc) 100mg Powder for Injection vial (217065) 27 November 2015 ARTG Australian Register of Therapeutic Goods (ARTG) information for REMSIMA infliximab (rmc) 100mg Powder for Injection vial.